Statements: RANBAXY USA, INC

Canonical ID: NK-ZrdPh55kVPUfjyK5fDWVmn · Entity type: Company (reference)

This table shows statement-based, sourced records from our database. For more context, learn about how OpenSanctions stores information.

Property	Value	Lang	Source dataset	Source ID	First seen
`Company:address`	C/O 750 E PRATT ST, STE 900, BALTIMORE, MD 21202	eng	us_hhs_exclusions	`us-fed-excl-ranbaxy-usa-inc-21202-baltimore`	2024-06-06
`Company:address`	750 E. Pratt Street Ste. 900, Baltimore MD 21202	eng	us_md_med_exclusions	`us-medmd-14311d98527b223178f9751843d6a836ed42463d`	2024-10-15
`Company:country`	us	eng	us_md_med_exclusions	`us-medmd-14311d98527b223178f9751843d6a836ed42463d`	2024-10-15
`Company:country`	us	eng	us_hhs_exclusions	`us-fed-excl-ranbaxy-usa-inc-21202-baltimore`	2024-05-08
`Company:description`	DRUG COMPANY/SUPLIER	eng	us_hhs_exclusions	`us-fed-excl-ranbaxy-usa-inc-21202-baltimore`	2024-05-08
`Company:description`	OTHER BUSINESS	eng	us_hhs_exclusions	`us-fed-excl-ranbaxy-usa-inc-21202-baltimore`	2024-05-08
`Company:id`	825f607c8289a9f8c9a87599a3f90c695b6a5f66	eng	us_md_med_exclusions	`us-medmd-14311d98527b223178f9751843d6a836ed42463d`	2024-10-15
`Company:id`	6a0dc31bf302f7dd12db8ba04140440b46241513	eng	us_hhs_exclusions	`us-fed-excl-ranbaxy-usa-inc-21202-baltimore`	2025-09-12
`Company:name`	Ranbaxy USA, Inc.	eng	us_md_med_exclusions	`us-medmd-14311d98527b223178f9751843d6a836ed42463d`	2024-10-15
`Company:name`	RANBAXY USA, INC	eng	us_hhs_exclusions	`us-fed-excl-ranbaxy-usa-inc-21202-baltimore`	2024-05-08
`Company:programId`	US-HHS-OIG	eng	us_hhs_exclusions	`us-fed-excl-ranbaxy-usa-inc-21202-baltimore`	2025-09-12
`Company:sector`	Business Entity	eng	us_md_med_exclusions	`us-medmd-14311d98527b223178f9751843d6a836ed42463d`	2024-10-15
`Company:topics`	debarment	eng	us_md_med_exclusions	`us-medmd-14311d98527b223178f9751843d6a836ed42463d`	2024-10-15
`Company:topics`	debarment	eng	us_hhs_exclusions	`us-fed-excl-ranbaxy-usa-inc-21202-baltimore`	2024-05-08

Previous
1 - 14 of 14
Next